Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare's Seraseq Myeloid Mutation DNA Mix and Myeloid RNA Fusion Mix

SeraCare Life Sciences has launched next-generation sequencing reference material for hematologic malignancies. The Seraseq Myeloid Mutation DNA Mix and Myeloid RNA Fusion Mix include mutation types from SNVs to gene fusions. The products contain 23 DNA mutations and nine fusion RNAs that are present against a well-characterized genomic background at clinically relevant allele frequencies. The products are designed to help clinical labs that perform NGS-based testing of myeloid malignancies to characterize their assays.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.